WOODMONT INVESTMENT COUNSEL LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 126 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOODMONT INVESTMENT COUNSEL LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$3,000
-25.0%
6750.0%0.00%0.0%
Q1 2016$4,000
-33.3%
6750.0%0.00%
-50.0%
Q4 2015$6,000
+50.0%
6750.0%0.00%
+100.0%
Q3 2015$4,0006750.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Alexandria Capital, LLC 916,153$8,740,0001.27%
Casdin Capital, LLC 1,080,000$10,303,0001.13%
Rhenman & Partners Asset Management AB 843,957$8,051,0000.94%
WASATCH ADVISORS LP 6,437,908$61,418,0000.67%
BB BIOTECH AG 2,650,000$25,281,0000.64%
Trellus Management Company, LLC 30,000$286,0000.54%
Opus Point Partners Management, LLC 33,529$320,0000.43%
SECTOR GAMMA AS 238,857$2,279,0000.36%
Leisure Capital Management 37,656$359,0000.30%
Ceeto Capital Group, LLC 41,000$391,0000.29%
View complete list of SANGAMO THERAPEUTICS INC shareholders